| 引用本文:李永明.中医药在美国参与抗疫的障碍和机遇[J].世界中医药,2020,(10):. |
|
| 中医药在美国参与抗疫的障碍和机遇 |
| Obstacles and Opportunities for Traditional Chinese Medicine's Participation in Anti-epidemic in the United States |
| 投稿时间：2020-03-13 |
| DOI：10.3969/j.issn.1673-7202.2020.10.031 |
| 中文关键词: 新型冠状病毒肺炎 中医药 障碍 机遇 |
| English Keywords:Corona Virus Disease 2019(COVID-19) Traditional Chinese medicine Obstacles Opportunities |
| 基金项目: |
|
| 摘要点击次数: 502 |
| 全文下载次数: 0 |
| 中文摘要: |
| 中医药治疗新型冠状病毒肺炎(以下简称新冠肺炎)的“中国经验”要进入美国医疗系统会遇到很多障碍，包括中医药的定位、医院系统的屏障、专业执照的限制等等。海外中医界期待中国中医药临床研究的数据能够跨过循证医学的门槛，希望能用不可拒绝的诉求，以破例的方式打开西方现有医疗制度的壁垒。其实，无论海外中医界最终能以何种方式参与，这次百年不遇的抗疫大战可能成为一次发展的契机。作者特别提醒海外中医界关注大疫之后医疗需求的变化和中医针灸擅长领域的真正机遇。 |
| English Summary: |
| The Chinese experience of TCM treatment for COVID-19 will encounter many obstacles in the US medical system, including the legal restrictions on TCM herbs, the barrier of the hospital system, and some limitations of professional licenses and so on. The overseas community of Chinese medicine expects that clinical research data from China will reach the threshold of evidence-based medicine, and hopes to use the irrefutable demands from the public, by way of exception to open the barriers of the existing Western medical system. In fact, no matter how doctors in Chinese medicine can finally participate, this once-in-a-century pandemic may become an opportunity for overseas TCM development. The author particularly reminds overseas practitioners to pay attention to the changes in medical needs after the pandemic and the real opportunities for Chinese medicine and acupuncture in the management of post pandemic conditions. |
| 查看全文 查看/发表评论 下载PDF阅读器 |
